- Home
- SKLZ vs BLUE Comparison
SKLZ vs BLUE Comparison
Compare SKLZ & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKLZ
- BLUE
- Stock Information
- Founded
- SKLZ 2012
- BLUE 1992
- Country
- SKLZ United States
- BLUE United States
- Employees
- SKLZ N/A
- BLUE N/A
- Industry
- SKLZ EDP Services
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SKLZ Technology
- BLUE Health Care
- Exchange
- SKLZ Nasdaq
- BLUE Nasdaq
- Market Cap
- SKLZ 94.7M
- BLUE 82.2M
- IPO Year
- SKLZ N/A
- BLUE 2013
- Fundamental
- Price
- SKLZ $6.26
- BLUE $8.35
- Analyst Decision
- SKLZ Buy
- BLUE Hold
- Analyst Count
- SKLZ 2
- BLUE 9
- Target Price
- SKLZ $10.75
- BLUE $49.14
- AVG Volume (30 Days)
- SKLZ 164.0K
- BLUE 328.0K
- Earning Date
- SKLZ 03-13-2025
- BLUE 11-14-2024
- Dividend Yield
- SKLZ N/A
- BLUE N/A
- EPS Growth
- SKLZ N/A
- BLUE N/A
- EPS
- SKLZ N/A
- BLUE N/A
- Revenue
- SKLZ $106,198,000.00
- BLUE $53,120,000.00
- Revenue This Year
- SKLZ N/A
- BLUE $145.88
- Revenue Next Year
- SKLZ $8.15
- BLUE $239.89
- P/E Ratio
- SKLZ N/A
- BLUE N/A
- Revenue Growth
- SKLZ N/A
- BLUE 144.50
- 52 Week Low
- SKLZ $4.33
- BLUE $5.80
- 52 Week High
- SKLZ $7.48
- BLUE $38.40
- Technical
- Relative Strength Index (RSI)
- SKLZ 67.28
- BLUE 49.21
- Support Level
- SKLZ $5.13
- BLUE $7.96
- Resistance Level
- SKLZ $6.43
- BLUE $8.75
- Average True Range (ATR)
- SKLZ 0.33
- BLUE 0.69
- MACD
- SKLZ 0.13
- BLUE -0.05
- Stochastic Oscillator
- SKLZ 88.74
- BLUE 23.72
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.